Search

everythinglearnresearchcommunity

for

Search:↓

A 4-year-old girl with a rare lupus condition was successfully treated with oral corticosteroids, leading to full recovery and hair regrowth.

Corticosteroids regrow hair better and faster than pentoxifylline for alopecia areata.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Targeting LPA could help treat skin disorders.

Lrig1 marks a unique group of stem cells in mouse skin that can become different skin cell types.

PRP gel is a safe, affordable treatment needing trained staff and proper facilities.

Low-level laser therapy can boost cell activity and energy production.

Activating TLR3 helps improve skin and hair follicle regeneration after wounds.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

Type I interferons play a key role in the development of various skin diseases.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Radiological findings help distinguish LAM, PLCH, and BHD to avoid invasive tests.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

A mutation in the iRhom2 gene causes hairless mice due to abnormal hair follicle development.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Rituximab effectively managed a difficult case of juvenile lupus with complications, reducing the need for steroids.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

A patient developed a blister at the injection site after hepatitis C treatment.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Blocking the Mitochondrial Pyruvate Carrier causes stress in hair follicles, which can be reduced by an ISR inhibitor.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.